PMC:7247521 / 222-316
Annnotations
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T5","span":{"begin":17,"end":22},"obj":"NCBITaxon:10239"},{"id":"T6","span":{"begin":28,"end":41},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T7","span":{"begin":46,"end":55},"obj":"GO:0008152"},{"id":"T45473","span":{"begin":17,"end":22},"obj":"NCBITaxon:10239"},{"id":"T92290","span":{"begin":28,"end":41},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T26450","span":{"begin":46,"end":55},"obj":"GO:0008152"}],"text":"OVID-19 via anti-viral, anti-inflammatory and metabolic programming.\n• 9 QFPD ingredients pre"}